Search Results 91-100 of 11126 for Anabolic

  1. Muscle pain - Mayo Clinic

    From Mayo Clinic to your inbox. Sign up for free and stay up to date on research advancements, health tips, current health topics, and expertise on managing ...

  2. Multiple endocrine neoplasia, type 1 (MEN 1) - Doctors and departments - Mayo Clinic

    Learn about this rare condition that causes tumors to grow and too many hormones to be made.

  3. Testosterone in Treating Postmenopausal Patients with Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment - Mayo Clinic

    RATIONALE: Testosterone may help relieve moderate or severe arthralgia associated with the use of aromatase inhibitors, such as anastrozole or letrozole.

  4. Drugs and Supplements that Start with D - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “D” to learn about drug side effects, proper use and ...

  5. testosterone therapy Archives - Mayo Clinic News Network

  6. Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) Fibrosis - Mayo Clinic

    Anabolic steroids; Systemic glucocorticoids for more than 4 weeks at doses greater than replacement doses. Uncontrolled diabetes (HbA1c ≥9%) within 60 days ...

  7. Blood donation frequently asked questions - Mayo Clinic

    How long does it take to donate blood? Whole blood donation takes about 45-60 minutes. Apheresis blood donation (double red cells, platelets, plasma) takes ...

  8. Drugs and Supplements that Start with R - Mayo Clinic

    Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “R” to learn about drug side effects, proper use and ...

  9. Publications - Bart L. Clarke, M.D. - Mayo Clinic

    Abaloparatide: Recombinant human PTHrP (1-34) anabolic therapy for osteoporosis. Maturitas. 2017 Mar; 97:53-60 Epub 2016 Dec 15. View PubMed; Donegan D, Singh ...

  10. Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days - Mayo Clinic

    About this study. Evaluate the safety, tolerability, and efficacy of 28 days of treatment with ALLN-177 for reducing urinary oxalate excretion in patients ...